GlassScriptPhysician profile
Haibin Wang
NPI 1013112184
$22,807.96
in general payments reported to CMS, 2019-2025
13 companies · $1,623 in 2025
The $1,623 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,326 · 2020: $1,563 · 2021: $1,348 · 2022: $3,325 · 2023: $4,863 · 2024: $3,760 · 2025: $1,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,093 · Food and Beverage: $4,035 · Travel and Lodging: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,092.50 |
| Food and Beverage | $4,035.36 |
| Travel and Lodging | $1,118.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,718.86 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Medtronic, INC. | $2,918.58 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Medtronic USA, INC. | $2,662.60 | 2019-2020 | |
| Boston Scientific Corporation | $1,611.35 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $1,136.26 | 2019-2025 | |
| Relievant Medsystems, INC. | $1,125.46 | 2020-2023 | Intracept |
| Nalu Medical, INC. | $820.18 | 2024 | Nalu Neurostimulation System |
| Mml US, INC. | $266.88 | 2022-2025 | Reactiv8 |
| Vertos Medical, INC. | $180.00 | 2019-2023 | Mild Device Kit |
| Tersera Therapeutics LLC | $165.85 | 2019-2024 | Prialt |
| Globus Medical, INC. | $117.74 | 2025 | Senza |
| Spr Therapeutics, INC | $68.00 | 2023 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haibin Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.